QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
Free Trial

Compare Stocks

→ IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BTR
Beacon Tactical Risk ETF
$23.52
-0.2%		$23.91
$22.52
▼
$25.41
$25.16M0.471,009 shs35 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$2.18
+0.9%		$2.68
$1.92
▼
$24.13
$112.71M1.991.04 million shs138,787 shs
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BTR
Beacon Tactical Risk ETF
-0.17%-2.93%-2.04%+2.04%-5.81%
Outset Medical, Inc. stock logo
OM
Outset Medical
+3.85%-6.70%+8.00%-38.11%-87.64%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BTR
Beacon Tactical Risk ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
1.9405 of 5 stars		3.22.00.00.03.10.81.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BTR
Beacon Tactical Risk ETF
0.00
N/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
2.33
Hold$5.42148.47% Upside

Current Analyst Ratings

Latest OM and BTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/8/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageBuy$6.00
4/5/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeNeutral ➝ Buy$6.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BTR
Beacon Tactical Risk ETF
N/AN/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
$130.38M0.86N/AN/A$2.45 per share0.89

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BTR
Beacon Tactical Risk ETF
N/AN/A0.00∞N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
-$172.80M-$3.50N/AN/AN/A-132.54%-102.50%-52.42%5/1/2024 (Estimated)

Latest OM and BTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/21/2024Q4 2023
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.74-$0.77-$0.03-$0.77$30.40 million$30.51 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BTR
Beacon Tactical Risk ETF
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BTR
Beacon Tactical Risk ETF
N/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
1.06
5.26
4.37

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BTR
Beacon Tactical Risk ETF
N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A

Insider Ownership

CompanyInsider Ownership
BTR
Beacon Tactical Risk ETF
N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
3.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BTR
Beacon Tactical Risk ETF
N/A1.07 millionN/ANot Optionable
Outset Medical, Inc. stock logo
OM
Outset Medical
48051.70 million49.79 millionNot Optionable

OM and BTR Headlines

SourceHeadline
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
finance.yahoo.com - April 17 at 10:48 AM
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
businesswire.com - April 17 at 8:30 AM
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient CareOutset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
businesswire.com - April 15 at 8:30 AM
Outset Medical shares get Buy rating from BTIGOutset Medical shares get Buy rating from BTIG
investing.com - April 9 at 11:54 PM
BTIG Research Begins Coverage on Outset Medical (NASDAQ:OM)BTIG Research Begins Coverage on Outset Medical (NASDAQ:OM)
americanbankingnews.com - April 9 at 3:34 AM
Buy Rating And Bullish Price Target Sends Small Cap SoaringBuy Rating And Bullish Price Target Sends Small Cap Soaring
msn.com - April 8 at 5:51 PM
Outset Medical stock soars on optimistic analyst outlookOutset Medical stock soars on optimistic analyst outlook
massdevice.com - April 8 at 5:51 PM
Outset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue GrowthOutset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue Growth
markets.businessinsider.com - April 8 at 12:49 PM
BTIG Research Initiates Coverage on Outset Medical (NASDAQ:OM)BTIG Research Initiates Coverage on Outset Medical (NASDAQ:OM)
marketbeat.com - April 8 at 8:01 AM
Outset Medical (NASDAQ:OM) Upgraded to "Buy" at CL KingOutset Medical (NASDAQ:OM) Upgraded to "Buy" at CL King
marketbeat.com - April 5 at 8:20 AM
AO’s Treatment of Cash Deposits as Unexplained Without Adverse Material UnjustifiedAO’s Treatment of Cash Deposits as Unexplained Without Adverse Material Unjustified
taxguru.in - April 4 at 2:08 PM
Care Plan Your Doctor Would Usually Recommend For Acute Otitis MediaCare Plan Your Doctor Would Usually Recommend For Acute Otitis Media
msn.com - March 18 at 10:01 PM
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of DirectorsOutset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
businesswire.com - March 13 at 4:02 PM
Why Dialysis Stocks Are up TodayWhy Dialysis Stocks Are up Today
wsj.com - March 6 at 7:03 PM
Outset Medical to Present at the 44th Annual TD Cowen Health Care ConferenceOutset Medical to Present at the 44th Annual TD Cowen Health Care Conference
businesswire.com - February 26 at 9:00 AM
Outset Medical Full Year 2023 Earnings: EPS Misses ExpectationsOutset Medical Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 23 at 8:48 AM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)
markets.businessinsider.com - February 22 at 12:21 PM
Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call TranscriptOutset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 22 at 12:21 PM
Q4 2023 Outset Medical Inc Earnings CallQ4 2023 Outset Medical Inc Earnings Call
finance.yahoo.com - February 22 at 7:19 AM
Outset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlookOutset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlook
msn.com - February 21 at 5:51 PM
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsOutset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 21 at 5:51 PM
Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 ResultsOutset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results
finance.yahoo.com - February 21 at 5:51 PM
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsOutset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
businesswire.com - February 21 at 4:05 PM
Outset Medical Q4 2023 Earnings PreviewOutset Medical Q4 2023 Earnings Preview
msn.com - February 20 at 9:19 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Beacon Tactical Risk ETF

NYSEARCA:BTR
The Beacon Tactical Risk ETF (BTR) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an active fund-of-funds seeking capital appreciation. The fund invests equally across US equity sectors, while attempting to minimize losses in volatile markets BTR was launched on Apr 17, 2023 and is managed by Sammons Enterprises.
Outset Medical logo

Outset Medical

NASDAQ:OM
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.